Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of July 2024, with a specific reporting date of July 19, 2024. The filing serves to disclose a material event regarding the Company's stock listing status on the Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a regulatory event rather than a financial statement.
Material Changes
The primary material change disclosed is the receipt of a notification from Nasdaq indicating that the Company's common stock has failed to meet the minimum bid price requirement for continued listing. No other operational or financial changes were detailed in this specific document.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the Nasdaq notification. The filing does not provide specific financial guidance, future outlook, or detailed risk analysis beyond the immediate implication of the listing deficiency. The Company must now address this deficiency to maintain its listing status.
Investor Verification Checklist
- Verify the current trading price of Icecure Medical Ltd. common stock against the Nasdaq minimum bid price requirement.
- Review the full text of the press release (Exhibit 99.1) for details on the Company's plan to regain compliance.
- Check subsequent filings for updates on the Company's compliance status or potential delisting proceedings.
- Confirm if the Company has filed a plan to cure the deficiency within the timeframe allowed by Nasdaq rules.